Articles

Podcasts

Videos

Dr. Au spoke of how the new data provides an opportunity to think about how lifestyle intervention  focused on weight and moderate exercise can actually have meaningful impacts on patients with COPD.

David Au, MD, MS: Lifestyle Interventions for Weight Loss in Obese Patients with COPD

This model was responsible for correctly identifying 73% of patients with pulmonary arterial hypertension 6 months prior to a confirmed diagnosis.

Claims-Based Algorithm Identifies PAH 6 Months Prior to Diagnosis

Dr. Holly Keir cites "massive changes" in beta diversity following ICS withdrawals in patients with moderate to very severe COPD.

Holly Keir, PhD: Changes in Microbiome Observed Following ICS Withdrawal in Patients with COPD

Dr. Lugogo explains how the ProAir Digihaler was used to accurately monitor SABA use in patients with asthma -many of whom were overusing their medication- which could allow clinicians to make appropriate changes to treatment.

Nijira Lucia Lugogo, MD: Effectively Monitoring SABA Use with Digital Inhaler Technology

The new study provides insights into the physiological factors for greater AtoOxy efficacy and can be referenced when identifying patients who are most suited for the therapy.

Polysomnographic Endotypic Traits Associated with AtoOxy Efficacy in OSA

Elliot Israel, MD, and Juan Carlos Cardet, MD, MPH, join Lungcast to discuss their latest research into addressing Black and Latinx asthma outcome disparities.

How PREPARE Data, SMART Recommendations Alter Modern Asthma Strategy

Patients with a positive family history of OSA  tended to be female with more severe OSA based on a higher AHI.

Family History of OSA Contributes to Pathogenesis of the Condition

Obstructive sleep apnea has previously been associated with pulmonary hypertension in literature, with investigators citing a “complex and bidirectional relationship” between the 2 conditions. 

Significant OSA Prevalence in Pediatric Patients with Pulmonary Hypertension 

Investigators from this ATS session suggested THN therapy could be used to treat OSA, believing in to be “a simpler approach than incumbent technology with no sensor and an easier, proximal electrode implantation”.

OSPREY Trial Suggests THN Therapy Effective in Moderate to Severe OSA

Dr. Rizzo sits down with HCPLive to discuss the impact of air pollution and allergies on pulmonary health, as well as new research on pulmonary arterial hypertension.

Al Rizzo, MD: Detailing the Latest Data on Pulmonary Health from ATS 2022

Asthma

The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.

COPD

COPD condition center page, resources on the topics of medical news and expert insight into chronic obstructive pulmonary disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on COPD research, treatment, and drug development.

Deep Vein Thrombosis 

The HCPLive deep vein thrombosis page is a resource for medical news and expert insights on DVT. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.

Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

Pulmonology